Issue 13, 2017
From the journal:

Chemical Communications

Targeted tumor detection: guidelines for developing biotinylated diagnostics†

Joo Hee Jang,‡a   Woo Ri Kim,‡b   Amit Sharma,‡a   Suk Hee Cho,b   Tony D. James, ORCID logo *c   Chulhun Kang*b  and  Jong Seung Kim ORCID logo *a  

* Corresponding authors

a Department of Chemistry, Korea University, Seoul, Korea
E-mail: jongskim@korea.ac.kr

b The School of East-West Medical Science, Kyung Hee University, Yongin, Korea
E-mail: kangch@khu.ac.kr

c Department of Chemistry, University of Bath, Bath, UK
E-mail: T.D.James@bath.ac.uk

Abstract

The challenge in achieving precision medicine relies on how to advance and/or enhance new as well as old therapeutic strategies. Here, we highlight the significant role hydrophilicity of biotinylated fluorescent probe's plays on their cellular uptake behaviour.

Graphical abstract: Targeted tumor detection: guidelines for developing biotinylated diagnostics

About
Cited by
Related
Download options Please wait...

Supplementary files

Article information

DOI
https://doi.org/10.1039/C7CC00311K
Article type
Communication
Submitted
15 Jan 2017
Accepted
25 Jan 2017
First published
25 Jan 2017
This article is Open Access
Creative Commons BY license

Chem. Commun., 2017,53, 2154-2157

Permissions

Request permissions

Targeted tumor detection: guidelines for developing biotinylated diagnostics

J. H. Jang, W. R. Kim, A. Sharma, S. H. Cho, T. D. James, C. Kang and J. S. Kim, Chem. Commun., 2017, 53, 2154 DOI: 10.1039/C7CC00311K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements